ad image

Inhalation

1 / 1
The Exciting Potential of Inhalation Vaccines
Inhalation Vaccines

The Exciting Potential of Inhalation Vaccines

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-11-022-NI-10Nov 15, 2022
Kindeva Drug Deliver
Cannabinoids

Kindeva and BOL Pharma Using Low Global Warming Potential (GWP) Propellant in Development of Inhaled Cannabinoid Products

Kindeva Drug Deliver

PR-M05-22-06May 11, 2022
Developing a Novel Anti-Inflammatory for Patients with Severe Asthma
Respiratory Diseases

Developing a Novel Anti-Inflammatory for Patients with Severe Asthma

Robert Clarke, Ph.D

Kinaset Therapeutics

PAO-02-022-CL-13Mar 12, 2022
Integrating Development and Manufacturing Experience with Inhalation Solutions
Inhalation

Integrating Development and Manufacturing Experience with Inhalation Solutions

Recipharm AB

PAO-03-22-R250-02Mar 01, 2022
Supporting Inhalation Development for Both Drugs and Devices
Inhalation

Supporting Inhalation Development for Both Drugs and Devices

Vectura Group

PAO-04-22-R221-19Apr 14, 2021
The Future of Inhalation
Inhalation Design

The Future of Inhalation

Vectura Group

PAO-04-22-R221-17Apr 09, 2021
Developing and Characterizing DPI Formulations for Biologics
Formulation

Developing and Characterizing DPI Formulations for Biologics

Eunice Costa; Constança Cacela

Hovione

PAP-Q1-2019-CL-002Apr 12, 2019
FDA Approves First Inhaler with Built-in Sensors
Inhalation

FDA Approves First Inhaler with Built-in Sensors

Emilie Branch

Pharma's Almanac

PAO-M01-19-NI-009Jan 09, 2019
GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD
Inhalation

GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD

Emilie Branch

Pharma's Almanac

PAO-M05-18-NI-022May 31, 2018
Teva Pharmaceutical Industries
Inhalation

Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol

Teva Pharmaceutical Industries

PR-M02-18-NI-53Feb 15, 2018
COPD Patients Excited about AstraZeneca Trial Results
Clinical Trials

COPD Patients Excited about AstraZeneca Trial Results

Guy Tiene

Nice Insight

PAO-M02-18-NI-002Feb 01, 2018
Hovione
Inhalation

Hovione strengthens Inhalation Services portfolio

Hovione

PR-M01-18-NI-084Jan 24, 2018
Polyphor
Formulation

Polyphor AG: Polyphor Launches the Development of an Inhaled Formulation of its Antibiotic Murepavadin

Polyphor

PR-M10-17-NI-004Oct 13, 2017
AstraZeneca, Pieris Pharmaceuticals Join Forces to Combat Respiratory Diseases
Clinical Trials

AstraZeneca, Pieris Pharmaceuticals Join Forces to Combat Respiratory Diseases

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M05-17-NI-011May 11, 2017
1 / 1